ArticleTherapeutic advances in medical oncology2025

SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancers.

Claire Chator et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.